Categories: aggregated

Is Pfizer Buying Arena Pharmaceuticals to Get into the Cannabis Space or Do They Just Want IBS and Digestive Issue Drugs?

Mike Gladstone, global president and general manager of Pfizer Inflammation and Immunology unit, said that the acquisition of Arena is in line with the company’s capabilities and expertise in immunology and inflammatory-related conditions. Over the years, Pfizer has successfully created an innovation engine that develops potential medicines for patients worldwide with chronic and debilitating immuno-inflammatory conditions. The company understands that there is an urgent need to look into other treatment options with high potential, which is where Arena’s cannabinoid-drug pipeline comes in.

Jason

Share
Published by
Jason

Recent Posts

More Cannabis Purchases or Larger Sized Weed Orders, Which is Better in the Marijuana Industry?

Quantity vs. Frequency - One of the most significant distinctions between medical and recreational cannabis…

3 days ago

Grand Openings: New weed shops of America for November 2024

At least 10 states and Amsterdam have new stores for you. The post Grand Openings:…

4 days ago

Women Aged 19 to 30 Now Smoke More Weed Than Their Male Counterparts in Sesmic Consumer Shift

According to fresh data from the US National Institute on Drug Abuse, young women have…

4 days ago

True or False – Dispensaries Share Your Purchase and Medical Information with the State Government?

Many states have enacted strict privacy laws that prevent dispensaries from sharing customer data without…

4 days ago